药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Granisetron
Thalidomide
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Granisetron
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.
Granisetron
Suvorexant
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Granisetron
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.
Granisetron
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Vecuronium.
Granisetron
Rotigotine
Vecuronium may increase the sedative activities of Rotigotine.
Granisetron
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.
Granisetron
Paraldehyde
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Granisetron
Orphenadrine
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Granisetron
Methotrimeprazine
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Granisetron
Hydrocodone
Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Mechlorethamine
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pancuronium is combined with Oliceridine.
Mechlorethamine
Remimazolam
The risk or severity of sedation can be increased when Remimazolam is combined with Pancuronium.
Mechlorethamine
Magnesium
Pancuronium can cause a decrease in the absorption of Magnesium resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mechlorethamine
Lasmiditan
The risk or severity of adverse effects can be increased when Pancuronium is combined with Lasmiditan.
Mechlorethamine
Cyclobenzaprine
The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Pancuronium.
Mechlorethamine
Solriamfetol
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Pancuronium.
Mechlorethamine
Esketamine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Esketamine.
Mechlorethamine
Macimorelin
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Pancuronium.
Mechlorethamine
Medical Cannabis
The risk or severity of Tachycardia can be increased when Pancuronium is combined with Medical Cannabis.